Official UK procurement notice
Bowel Screening · UK public procurement notice
Authority: Milton Keynes University Hospital (Education)
What is being bought
Published requirement descriptionProvision of bowel cancer screening endoscopy services, primarily colonoscopy procedures, delivered in support of the NHS Bowel Cancer Screening Programme. The contract has been awarded under the Provider Selection Regime Direct Award Process C to ensure continuity of clinically safe and effective screening services.
CPV: Health services · Surgical hospital services
The lotProcurement structure
single lot · no lot value publishedLot #1This procurement relates to the provision of bowel cancer screening endoscopy services…Awarded
This procurement relates to the provision of bowel cancer screening endoscopy services primarily colonoscopy procedures delivered as part of the NHS Bowel Cancer Screening Programme. The services support the early detection of bowel cancer and the identification and removal of pre‑cancerous lesions in line with national screening standards.<br/>The contract has been awarded under the Provider Selection Regime Direct Award Process C as the existing provider is delivering the services to a satisfactory standard and continuity of clinically safe, effective, and accessible screening services is required. the lifetime of the service is to be 1 year at a cost of £142,594.40 and will begin 01.08.26 - 31.07.26. Additional information: Maintaining uninterrupted access to bowel screening is essential for patient pathways, early detection rates, and overall service outcomes. The PSR statutory guidance highlights that continuity of service, particularly in regulated clinical pathways, is a key consideration in determining the most suitable procurement route. <br/>The current providers at Saxon Clinic and Chiltern Clinic are already integrated into the screening pathway, workforce arrangements, booking systems, and reporting processes. Any cessation or change of provider would create gaps in delivery, resulting in cancelled appointments and reduced screening throughput.<br/>Therefore, continuity of service was essential and supported use of Direct Award C<br/>This contract has been awarded under<br/>the provision of the Provider Selection<br/>Regime (PSR). This contract has been<br/>awarded under the Health Care<br/>Services (Provider Selection Regime)<br/>regulations 2023. For the avoidance of<br/>doubt, the provision of the Public<br/>Contracts Regulations 2015 do not<br/>apply to this award.<br/>The award of contract is to Circle<br/>Health - Circle Health Group<br/>1st Floor<br/>30 Cannon Street<br/>LONDON<br/>EC4 M6X<br/>Sub-Contract Reference Circle Health<br/>Holdings H2 2023-2024<br/>Direct Award C requires publication of a<br/>notice of intention to award on the UK e<br/>notification service, followed by an 8<br/>working day standstill period, before<br/>contract award.<br/>MKUH has followed or will follow this<br/>process in line with the PSR<br/>transparency and accountability<br/>requirements.<br/>The award of contract is for 12 months.<br/>Conflicts of interest identified among<br/>the MKUH evaluators were none. The<br/>ono conflicted members have assessed<br/>the nature and risk of this conflict, and<br/>have decided which steps to take to<br/>avoid or manage it.<br/>An evaluation using the PSR template<br/>has been completed and agreed by all<br/>evaluators.<br/>Representations by providers must be<br/>made to decision makers by [Add date].<br/>This contract has not yet formally been<br/>awarded; this notice serves as an<br/>intention to award under the PSR.<br/>[email protected] - responses<br/>can be received here with the subject<br/>title FTS-019926.<br/>The 5 key criteria have been assessed<br/>of 1. Quality and Innovation. 2. Value.<br/>3. Intergration and collaboration. 4.<br/>Improving access. 5. Social value.<br/>This is a Provider Selection Regime<br/>(PSR) intention to award notice. The<br/>awarding of this contract is subject to<br/>the Health Care Services (Provider Selection Regime) Regulations 2023.<br/>For the avoidance of doubt, the<br/>provisions of the Public Contracts<br/>Regulations 2015 do not apply to this<br/>award. The standstill period begins on<br/>the day after the publication of this<br/>notice. Representations by providers<br/>must be made to the relevant authority<br/>by [Add date]. This contract has not yet<br/>formally been awarded; this notice<br/>serves as an intention to award under<br/>the PSR
Procedure terms & legal framework
From the official record · publisher note attached- Procedure method
- Award procedure without prior publication of a call for competition
- Legal basis
- CELEX · 32014L0024 Public Contracts Regulations 2015 (Directive 2014/24/EU)
- Procurement category
- Services
- Notice status
- Awarded without competition
- Procurement threshold
- Unspecified in notice
- Regulatory regime
- Standard
- Commercial structure
- Stand-alone contract (no framework)
- Competition type
- Direct award (no call for competition)
- GPA / WTO covered
- Yes (GPA)
- Recurring procurement
- Unspecified in notice
- First published
- 14 May 2026, 11:49 BST
- Last source update
- 14 May 2026, 11:49 BST
- Authority reference
C44266- FTS notice number
2026/S 000-044312- Classification (CPV)
- Delivery area
- Official registry OCID
ocds-h6vhtk-06989aFind a Tender
- Why no open competition
- The procurement falls outside the scope of application of the directive
- Published justification
This contract has been awarded to a single economic operator under the Provider Selection Regime (Direct Award Process C). The existing provider is currently delivering the bowel cancer screening services to a satisfactory standard and is expected to continue to do so under the proposed contract. The scope of the services and contractual arrangements are not changing considerably, and continuity of clinically safe, effective, and accredited screening services is required. In accordance with the Health Care Services (Provider Selection Regime) Regulations 2023, a competitive process involving multiple operators was not considered necessary or appropriate.
- Review procedure
continuity of clinical services, preservation of critical KPIs, operational necessity, provider suitability, and avoidance of disruption—MKUH determined that a PSR Direct Award Process C is the most appropriate, lawful, and risk minimising mechanism for awarding the bowel screening services at Saxon Clinic and Chiltern Clinic.<br/>This approach is fully aligned with the statutory PSR guidance issued by NHS England and the requirements set out in the 2023 Regulations
Publisher note: This contract has been awarded under the provision of the Provider Selection Regime (PSR). This contract has been awarded under the Health Care Services (Provider Selection Regime) regulations 2023. For the avoidance of doubt, the provision of the Public Contracts Regulations 2015 do not apply to this award.<br/><br/>The award of contract is to Circle Health - Circle Health Group <br/>1st Floor <br/>30 Cannon Street <br/>LONDON <br/>EC4 M6X <br/>Sub-Contract Reference Circle Health Holdings H2 2023-2024<br/><br/>Direct Award C requires publication of a notice of intention to award on the UK e notification service, followed by an 8 working day standstill period, before contract award. <br/>MKUH has followed or will follow this process in line with the PSR transparency and accountability requirements.<br/>The award of contract is for 12 months.<br/><br/>Conflicts of interest identified among the MKUH evaluators were none. The ono conflicted members have assessed the nature and risk of this conflict, and have decided which steps to take to avoid or manage it. <br/>An evaluation using the PSR template has been completed and agreed by all evaluators.<br/><br/>Representations by providers must be made to decision makers by [Add date]. This contract has not yet formally been awarded; this notice serves as an intention to award under the PSR.<br/><br/>[email protected] - responses can be received here with the subject title FTS-019926.<br/><br/>The 5 key criteria have been assessed of 1. Quality and Innovation. 2. Value. 3. Intergration and collaboration. 4. Improving access. 5. Social value.<br/><br/>This is a Provider Selection Regime (PSR) intention to award notice. The awarding of this contract is subject to the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 do not apply to this award. The standstill period begins on the day after the publication of this notice. Representations by providers must be made to the relevant authority by [Add date]. This contract has not yet formally been awarded; this notice serves as an intention to award under the PSR
Commercial outcome & contract awards
Published awards, contracts and bid statistics, not a forecast| Awarded to | Value | Date | Status |
|---|---|---|---|
| Circle Health Group Limited | £142,450 † | — | Awarded |
Contracts
Contract 044312-2026-1 · Circle Health Group Limited
- Signed
- 7 May 2026
- Value
- £142,450
- Status
- active
Bid statistics published by the authority
| Bids | SME | VCSE | Valid bid range |
|---|---|---|---|
| 1bids · 0 electronic | 0 | — | — |
Contracting authority & participating public bodies
Dispute resolution & review bodies
- The High CourtReview body
Bidders & participating suppliers
1 commercial party on the notice- Circle Health Group LimitedAwarded supplier
Official documents & specifications
Official links; attachments are not copiedNo document links were published on the notice.